IL6 and multiple sclerosis: WIN-mediated attenuation of IL-6 expression leading to a decrease in neuroinflammation was also described in aged rats [45] and in an experimental autoimmune encephalomyelitis model mimicking essential pathological features with multiple sclerosis [46].